Effect of hyperhomocysteinemia on endothelial activation and dysfunction in patients with end-stage renal disease

被引：6
|
作者：
Ishikawa, M [1 ]
Namiki, A [1 ]
Kubota, T [1 ]
Fukazawa, M [1 ]
Joki, N [1 ]
Moroi, M [1 ]
Suzuki, M [1 ]
Hase, H [1 ]
Yamaguchi, T [1 ]
机构：
[1] Toho Univ, Ohashi Hosp, Sch Med, Dept Internal Med 3,Meguro Ku, Tokyo 1538515, Japan
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2001年 / 88卷 / 10期
关键词：
D O I：
10.1016/S0002-9149(01)02064-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Total plasma homocysteine concentration was elevated in patients with end-stage renal disease (ESRD), and concentrations of thrombomodulin, von Willebrand factor, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin were significantly higher in patients with hyperhomocysteinemia or ESP-D. Hyperhomocysteinemia in patients with ESRD induces endothelial activation and dysfunction, and may contribute to atherogenesis.
引用
收藏
页码：1203 / +
页数：5
相关论文
共 50 条
  • [1] Endothelial dysfunction in patients with end-stage renal failure
    Dammers, R
    Hameleers, JM
    Tordoir, JH
    Welten, RJ
    Hoeks, AP
    Kitslaar, PJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : A77 - A77
  • [2] Treatment of hyperhomocysteinemia in end-stage renal disease
    Shemin, D
    Bostom, AG
    Selhub, J
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : S91 - S94
  • [3] Glymphatic Dysfunction in Patients With End-Stage Renal Disease
    Heo, Chang Min
    Lee, Won Ho
    Park, Bong Soo
    Lee, Yoo Jin
    Park, Sihyung
    Kim, Yang Wook
    Lee, Dong Ah
    Yoo, Byeong Cheol
    Park, Kang Min
    [J]. FRONTIERS IN NEUROLOGY, 2022, 12
  • [4] Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease
    Elian, KM
    Hoffer, LJ
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (07): : 881 - 886
  • [5] Mechanisms of Endothelial Dysfunction in Resistance Arteries from Patients with End-Stage Renal Disease
    Luksha, Leanid
    Stenvinkel, Peter
    Hammarqvist, Folke
    Carrero, Juan Jesus
    Davidge, Sandra T.
    Kublickiene, Karolina
    [J]. PLOS ONE, 2012, 7 (04):
  • [6] Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease
    Dierkes, J
    Domröse, U
    Ambrosch, A
    Bosselmann, HP
    Neumann, KH
    Luley, C
    [J]. CLINICAL NEPHROLOGY, 1999, 51 (02) : 108 - 115
  • [7] Hyperhomocysteinemia and end-stage renal disease: Determinants and association with cardiovascular disease in Tunisian patients
    Fellah, H
    Feki, M
    Hsairi, M
    Sanhaji, H
    Kaabachi, N
    Ben Abdallah, T
    Massy, ZA
    Ben Maiz, H
    Lacour, B
    Mebazaa, A
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (05) : 675 - 680
  • [8] Right ventricular dysfunction in patients with end-stage renal disease
    Benzarouel, D.
    El Hattaoui, M.
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 : 826 - 826
  • [9] Right Ventricular Dysfunction in Patients with End-Stage Renal Disease
    Paneni, Francesco
    Gregori, Mario
    Ciavarella, Giuseppino Massimo
    Sciarretta, Sebastiano
    De Biase, Luciano
    Marino, Laura
    Tocci, Giuliano
    Principe, Francesco
    Domenici, Alessandro
    Luciani, Remo
    Punzo, Giorgio
    Mene, Paolo
    Volpe, Massimo
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2010, 32 (05) : 432 - 438
  • [10] Right ventricular dysfunction in patients with end-stage renal disease
    Paneni, F.
    Gregori, M.
    Ciavarella, G. M.
    Sciarretta, S.
    De Biase, L.
    Marino, L.
    Punzo, G.
    Mene, P.
    Volpe, M.
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 : 753 - 754
12345